# | Title | Journal | Year | Citations |
---|
|
1 | METLIN | Therapeutic Drug Monitoring | 2005 | 2,008 |
2 | Population Pharmacokinetic Modeling and Optimal Sampling Strategy for Bayesian Estimation of Amikacin Exposure in Critically Ill Septic Patients | Therapeutic Drug Monitoring | 2010 | 595 |
3 | Dried Blood Spot Methods in Therapeutic Drug Monitoring: Methods, Assays, and Pitfalls | Therapeutic Drug Monitoring | 2009 | 458 |
4 | Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report | Therapeutic Drug Monitoring | 2019 | 421 |
5 | Detection Times of Drugs of Abuse in Blood, Urine, and Oral Fluid | Therapeutic Drug Monitoring | 2004 | 415 |
6 | Accurate Detection of Outliers and Subpopulations With Pmetrics, a Nonparametric and Parametric Pharmacometric Modeling and Simulation Package for R | Therapeutic Drug Monitoring | 2012 | 412 |
7 | Organophosphate Pesticides: Biochemistry and Clinical Toxicology | Therapeutic Drug Monitoring | 2002 | 407 |
8 | Opportunities to Optimize Tacrolimus Therapy in Solid Organ Transplantation: Report of the European Consensus Conference | Therapeutic Drug Monitoring | 2009 | 400 |
9 | Human Pharmacology of MDMA | Therapeutic Drug Monitoring | 2004 | 397 |
10 | Mode of Action of Tacrolimus (FK506): Molecular and Cellular Mechanisms | Therapeutic Drug Monitoring | 1995 | 336 |
11 | Clinically Important Drug Interactions Potentially Involving Mechanism-based Inhibition of Cytochrome P450 3A4 and the Role of Therapeutic Drug Monitoring | Therapeutic Drug Monitoring | 2007 | 328 |
12 | Therapeutic Drug Monitoring of Antiepileptic Drugs in Epilepsy: A 2018 Update | Therapeutic Drug Monitoring | 2018 | 320 |
13 | Therapeutic Drug Monitoring of Mycophenolate Mofetil in Transplantation | Therapeutic Drug Monitoring | 2006 | 307 |
14 | Therapeutic Drug Monitoring of the Newer Antiepileptic Drugs | Therapeutic Drug Monitoring | 2003 | 295 |
15 | Comparison of the Effects of Tacrolimus and Cyclosporine on the Pharmacokinetics of Mycophenolic Acid | Therapeutic Drug Monitoring | 2001 | 293 |
16 | Fluvoxamine Inhibition and Carbamazepine Induction of the Metabolism of Clozapine | Therapeutic Drug Monitoring | 1994 | 285 |
17 | Methods for Quantification of Exposure to Cigarette Smoking and Environmental Tobacco Smoke: Focus on Developmental Toxicology | Therapeutic Drug Monitoring | 2009 | 282 |
18 | Rapamune (Sirolimus, Rapamycin): An Overview and Mechanism of Action | Therapeutic Drug Monitoring | 1995 | 273 |
19 | Mechanism of Action of Mycophenolate Mofetil | Therapeutic Drug Monitoring | 1995 | 262 |
20 | Consensus Document: Therapeutic Monitoring of Tacrolimus (FK-506) | Therapeutic Drug Monitoring | 1995 | 259 |
21 | Acyl Glucuronide Drug Metabolites: Toxicological and Analytical Implications | Therapeutic Drug Monitoring | 2003 | 252 |
22 | Clinical Pharmacokinetics of Morphine | Therapeutic Drug Monitoring | 1991 | 251 |
23 | Pharmacokinetics and Pharmacodynamics in Clinical Use of Scopolamine | Therapeutic Drug Monitoring | 2005 | 248 |
24 | Current Issues in Therapeutic Drug Monitoring of Mycophenolic Acid: Report of a Roundtable Discussion | Therapeutic Drug Monitoring | 2001 | 240 |
25 | Role of P-Glycoprotein in Drug Disposition | Therapeutic Drug Monitoring | 2000 | 235 |
26 | Lake Louise Consensus Conference on Cyclosporin Monitoring in Organ Transplantation: Report of the Consensus Panel | Therapeutic Drug Monitoring | 1995 | 227 |
27 | Use and Abuse of the Benzodiazepines | Therapeutic Drug Monitoring | 1998 | 225 |
28 | Impact of Goal-Oriented and Model-Based Clinical Pharmacokinetic Dosing of Aminoglycosides on Clinical Outcome: A Cost-Effectiveness Analysis | Therapeutic Drug Monitoring | 1999 | 219 |
29 | Official International Association for Therapeutic Drug Monitoring and Clinical Toxicology Guideline: Development and Validation of Dried Blood Spot–Based Methods for Therapeutic Drug Monitoring | Therapeutic Drug Monitoring | 2019 | 214 |
30 | Review of Biologic Matrices (Urine, Blood, Hair) as Indicators of Recent or Ongoing Cannabis Use | Therapeutic Drug Monitoring | 2006 | 213 |
31 | Pharmacokinetics of Citalopram in Relation to the Sparteine and the Mephenytoin Oxidation Polymorphisms | Therapeutic Drug Monitoring | 1993 | 210 |
32 | Toxicokinetics of Amphetamines: Metabolism and Toxicokinetic Data of Designer Drugs, Amphetamine, Methamphetamine, and Their N-Alkyl Derivatives | Therapeutic Drug Monitoring | 2002 | 202 |
33 | Cost-Effectiveness of Therapeutic Drug Monitoring | Therapeutic Drug Monitoring | 2005 | 190 |
34 | Hair Analysis for Drug Detection | Therapeutic Drug Monitoring | 2006 | 190 |
35 | Genetic Polymorphism of Cytochrome P450s, CYP2C19, and CYP2C9 in a Japanese Population | Therapeutic Drug Monitoring | 1998 | 188 |
36 | Pharmacogenetics of Thiopurine S-Methyltransferase and Thiopurine Therapy | Therapeutic Drug Monitoring | 2004 | 185 |
37 | Therapeutic Drug Monitoring of Antiepileptic Drugs by Use of Saliva | Therapeutic Drug Monitoring | 2013 | 177 |
38 | Slow Omeprazole Metabolizers Are Also Poor S-Mephenytoin Hydroxylators | Therapeutic Drug Monitoring | 1990 | 176 |
39 | Haloperidol Disposition Is Dependent on Debrisoquine Hydroxylation Phenotype | Therapeutic Drug Monitoring | 1992 | 174 |
40 | Infliximab Pharmacokinetics in Inflammatory Bowel Disease Patients | Therapeutic Drug Monitoring | 2008 | 173 |
41 | Biomarkers of Drug-Induced Kidney Toxicity | Therapeutic Drug Monitoring | 2019 | 172 |
42 | Pharmacokinetic and Metabolic Investigations of Mycophenolic Acid in Pediatric Patients After Renal Transplantation: Implications for Therapeutic Drug Monitoring | Therapeutic Drug Monitoring | 2000 | 172 |
43 | Evidence That Tacrolimus Augments the Bioavailability of Mycophenolate Mofetil Through the Inhibition of Mycophenolic Acid Glucuronidation | Therapeutic Drug Monitoring | 1999 | 171 |
44 | Clinical Aspects of the MDR1 (ABCB1) Gene Polymorphism | Therapeutic Drug Monitoring | 2004 | 170 |
45 | Population Pharmacokinetics of Metformin in Late Pregnancy | Therapeutic Drug Monitoring | 2006 | 170 |
46 | Itraconazole Decreases Renal Clearance of Digoxin | Therapeutic Drug Monitoring | 1997 | 169 |
47 | Pharmacologic Analysis of Drug Receptor Interaction | Therapeutic Drug Monitoring | 1988 | 166 |
48 | Population Pharmacokinetic and Pharmacodynamic Analysis of Ribavirin in Patients With Chronic Hepatitis C | Therapeutic Drug Monitoring | 2000 | 164 |
49 | Randomized, Double-Blind, Placebo-Controlled Study About the Effects of Cannabidiol (CBD) on the Pharmacokinetics of ??9-Tetrahydrocannabinol (THC) After Oral Application of THC Verses Standardized Cannabis Extract | Therapeutic Drug Monitoring | 2005 | 158 |
50 | Extremely Rapid Hydroxylation of Debrisoquine | Therapeutic Drug Monitoring | 1985 | 151 |